The following is a list of initial public offerings that priced during the week of Aug. 2-6.
Ambow Education Holding Ltd. (NYSE: AMBO), a provider of online and offline tutoring, test prep and career enhancement services in China, based in Beijing, priced 10.7 million American depositary shares, each representing 2 class A ordinary shares, at $10 each on Aug. 4. The price was at the low end of the $10 to $12 filing range. J.P. Morgan and Goldman Sachs Asia were the lead managers. The shares closed the first day, Thursday, at $9.25, and ended the week at $8.45 down $1.55 from the offering price.
D. Medical Industries Ltd. (Nasdaq: DMED), a medical device company that develops and manufactures insulin pumps, based in Ramat-Gan, Israel, priced 1.5 million ordinary shares at $7 each on Aug. 4. The price was at the low end of the $7 to $9 filing range, which was revised three times and was originally filed at $10 to $12. The number of shares offered was reduced by 1 million. Rodman & Renshaw and ThinkEquity were the lead managers. The shares had been trading exclusively in Tel Aviv. The shares closed the first day, Thursday, at $6.25, and ended the week at $6.44, down 56 cents from the offering price.
Gordmans Stores Inc. (Nasdaq: GMAN), an Omaha, Neb.-based off-price department store chain operating 67 stores in the Midwest, priced 5.4 million shares, at $11 each on Aug. 4. The price was below the $13 to $15 filing range. Piper Jaffray and Wells Fargo Securities were the lead managers. The stock closed the first day, Thursday, at $11.01, and ended the week at $10.85, 15 cents below the offering price.
IntraLinks Holdings Inc. (NYSE: IL), a New York-based provider of secure online document management to over 4,300 customers worldwide, priced 11 million shares at $13 each on Aug. 5. The price was below the $14 to $16 filing range. Morgan Stanley, Deutsche Bank, and Credit Suisse were the lead managers. The stock closed the first day, Friday, flat at $13.
NuPathe Inc. (Nasdaq: PATH) priced 5 million shares at $10 each on Aug. 5. The price was well below the $14 to $16 filing range. Leerink Swann and Lazard Capital Markets were the lead managers. The Conshohocken, Pa.-based specialty pharma is seeking approval for Zelrix, a patch for migraine treatment. The stock closed the first day, Friday, at $9.61, 39 cents below the offering price.
NXP Semiconductors N.V. (Nasdaq: NXPI), a Netherlands-based global semiconductor company that designs products for auto, industrial and mobile industries, priced 34 million shares at $14 each on Aug. 5. The price was well below the $18 to $21 filing range. Credit Suisse, Goldman Sachs, and Morgan Stanley were the lead managers. The stock closed the first day, Friday, flat at $14.
Trius Therapeutics Inc. (Nasdaq: TSRX) a San Diego-based biotech which is developing antibiotics for serious life-threatening infections, priced 10 million shares at $5 each on Aug. 2. The price was at the revised filing amount after the company lowered its asking price from the originally filed $12 to $14. Four million additional shares were offered to help raise the proceeds. Citigroup and Piper Jaffray were the lead managers. The stock closed the first day, Tuesday, flat at $5, and also ended the week at $5 unchanged from the offering price.
